ADHD Drugmaker To Ease Ongoing Shortage By Increasing Production
The Drug Enforcement Administration increased the production limit for Takeda Pharmaceutical’s ADHD drug Vyvanse and its generic versions by about 24% to address the medicine’s ongoing shortage in the United States. What do you think?…